1532-950X/asset/olbannercenter.gif?v=1&s=31a20e7fcb54188964bb11d79af8d0d141af9dee)
Invited Review
Worldwide Screening for Canine Hip Dysplasia: Where Are We Now?
Article first published online: 23 JAN 2012
DOI: 10.1111/j.1532-950X.2011.00929.x
© Copyright 2011 by The American College of Veterinary Surgeons
Additional Information
How to Cite
Verhoeven, G., Fortrie, R., Van Ryssen, B. and Coopman, F. (2012), Worldwide Screening for Canine Hip Dysplasia: Where Are We Now?. Veterinary Surgery, 41: 10–19. doi: 10.1111/j.1532-950X.2011.00929.x
Publication History
- Issue published online: 23 JAN 2012
- Article first published online: 23 JAN 2012
- Manuscript Accepted: MAY 2011
- Manuscript Received: MAY 2010
- Abstract
- Article
- References
- Cited By
Objective
To critically review the different screening systems used for canine hip dysplasia (CHD) and their impact on the prevalence of the disease.
Study design
Critical literature review.
Methods
Literature search through PubMed (November 1959–October 2011) and the Orthopedic Foundation for Animals (OFA), Fédération Cynologique Internationale (FCI), British Veterinary Association/Kennel Club (BVA/KC), and Pennsylvania Hip Improvement Program (PennHIP) websites.
Results
The OFA, FCI, and BVA/KC screening methods, which use the hip-extended radiographic projection, have had relatively minor success on CHD prevalence. These screening approaches are prone to conflicting data regarding interobserver agreement. The PennHIP and Dorsolateral Subluxation (DLS) systems, both distraction methods, have not reported on prevalence but seem to be important heritable traits in genomic screening of dysplastic dogs.
Conclusion
A shift towards genome screening yields a promising future combating CHD, although further investigation towards fine-mapping in the search for genes, responsible for CHD, is necessary.